MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 39 filers reported holding MARINUS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $256,000 | -15.0% | 100,934 | -32.2% | 0.00% | – |
| Q1 2020 | $301,000 | -4.1% | 148,954 | +2.4% | 0.00% | – |
| Q4 2019 | $314,000 | +31.4% | 145,464 | -6.1% | 0.00% | – |
| Q3 2019 | $239,000 | -93.3% | 154,866 | -82.0% | 0.00% | -100.0% |
| Q2 2019 | $3,571,000 | +80.2% | 860,443 | +81.6% | 0.00% | +100.0% |
| Q1 2019 | $1,982,000 | +6.8% | 473,830 | -26.7% | 0.00% | – |
| Q4 2018 | $1,855,000 | -34.0% | 646,489 | +130.0% | 0.00% | -100.0% |
| Q3 2018 | $2,810,000 | +206.8% | 281,045 | +116.8% | 0.00% | – |
| Q2 2018 | $916,000 | +307.1% | 129,626 | +120.0% | 0.00% | – |
| Q1 2018 | $225,000 | -97.3% | 58,929 | -94.2% | 0.00% | -100.0% |
| Q4 2017 | $8,340,000 | +2670.8% | 1,022,113 | +1889.2% | 0.01% | – |
| Q3 2017 | $301,000 | +1781.2% | 51,383 | +327.8% | 0.00% | – |
| Q2 2017 | $16,000 | -75.0% | 12,012 | -66.5% | 0.00% | – |
| Q1 2017 | $64,000 | – | 35,822 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,192,883 | $15,329,000 | 3.00% |
| Bain Capital Life Sciences Investors, LLC | 1,431,059 | $18,389,000 | 1.71% |
| Avoro Capital Advisors LLC | 3,000,000 | $38,550,000 | 0.55% |
| Palo Alto Investors LP | 31,330 | $403,000 | 0.02% |